A253840 Stock Overview
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Sugentech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,630.00 |
| 52 Week High | ₩11,200.00 |
| 52 Week Low | ₩5,610.00 |
| Beta | -2.82 |
| 1 Month Change | -24.43% |
| 3 Month Change | -15.34% |
| 1 Year Change | -30.24% |
| 3 Year Change | -82.94% |
| 5 Year Change | -59.79% |
| Change since IPO | -9.92% |
Recent News & Updates
Recent updates
We Like Sugentech's (KOSDAQ:253840) Returns And Here's How They're Trending
Apr 14
Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly
Mar 09If You Had Bought Sugentech (KOSDAQ:253840) Stock A Year Ago, You Could Pocket A 139% Gain Today
Feb 02
Is Sugentech (KOSDAQ:253840) The Next Multi-Bagger?
Dec 29Sugentech (KOSDAQ:253840) Seems To Use Debt Quite Sensibly
Dec 03Shareholder Returns
| A253840 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -1.2% | 6.5% | 0.5% |
| 1Y | -30.2% | 32.1% | 4.7% |
Return vs Industry: A253840 underperformed the KR Medical Equipment industry which returned 32.1% over the past year.
Return vs Market: A253840 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A253840 volatility | |
|---|---|
| A253840 Average Weekly Movement | 10.1% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A253840's share price has been volatile over the past 3 months.
Volatility Over Time: A253840's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 137 | Sohn Mi | sugentech.com |
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers Multiplex BLOT disease diagnostic devices, such as immunoblot processor, semi and full automation, and molecular diagnostic systems, as well as test items; and self-testing products, including digital ovulation, pregnancy test, and early sign pregnancy test, as well as mobile testing products. It also provides point of care testing analyzers and test items for testing of M.tuberculosis, M.bovis, SARS-CoV-2 antibodies and antigens, flu A/B antigens, and CRP/hsCRP /dualCRP, as well as for measuring procalcitonin, troponin I, hemoglobinA1c, human chorionic gonadotropin, immunoglobulin E, and influenza A/B.
Sugentech Inc. Fundamentals Summary
| A253840 fundamental statistics | |
|---|---|
| Market cap | ₩85.96b |
| Earnings (TTM) | -₩17.24b |
| Revenue (TTM) | ₩7.13b |
12.1x
P/S Ratio-5.0x
P/E RatioIs A253840 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A253840 income statement (TTM) | |
|---|---|
| Revenue | ₩7.13b |
| Cost of Revenue | ₩11.46b |
| Gross Profit | -₩4.33b |
| Other Expenses | ₩12.91b |
| Earnings | -₩17.24b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.13k |
| Gross Margin | -60.74% |
| Net Profit Margin | -241.69% |
| Debt/Equity Ratio | 12.8% |
How did A253840 perform over the long term?
See historical performance and comparison